APO Group - Africa Newsroom / Press Release africa-newsroom.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from africa-newsroom.com Daily Mail and Mail on Sunday newspapers.
All-New Six-Episode Event Series “Iwájú” is a First-of-its-Kind Collaboration between Walt Disney Animation Studios and Pan-African Entertainment Company Kugali
Riot Games Reaches Groundbreaking Global Partnership With Gaming Brands OMEN And Hyperx menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Targeted News Service provides Washington Bureau coverage, federal contract and contracting information for awards and for subcontracting opportunities, a congressional vote chart, federal and congressional press releases.
Share:
Allogene Overland Biopharm, a First-of-its-Kind Collaboration in Allogeneic Cell Therapy, Is Dedicated to Making AlloCAR T™ Available to Patients in Greater China, Taiwan, South Korea and Singapore
The Joint Venture Provides An Opportunity to Accelerate the Global Development of AlloCAR T Therapies for Hematologic Malignancies and Solid Tumors
Overland, Backed by Hillhouse Capital, to Invest $117 Million in Capital, Which Includes an Upfront Payment to Allogene and Financial Support to Joint Venture Operations
SOUTH SAN FRANCISCO, Calif. and BOSTON and SHANGHAI, China, Dec. 15, 2020 (GLOBE NEWSWIRE) Allogene Therapeutics, Inc. (NASDAQ:ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for cancer, and Overland Pharmaceuticals ( Overland ), a premier biopharmaceutical company backed by Hillhouse Capital, today announced the formation of Allogene Overland Biopharm (Allogene Overland). The joint venture